| MPs | Mononuclear phagocytes |
| HIV | Human immunodeficiency virus |
| ART | Antiretroviral therapy |
| CNS | Central nervous system |
| CTL | Cytotoxic T lymphocyte |
| MOI | Multiplicity of infection |
| PKC | Protein kinase C |
| PLWH | People living with HIV |
| MDMs | Monocyte-derived macrophages |
| NHP | Nonhuman primate |
| BnAbs | Broadly neutralizing antibodies |
| CAR T | Chimeric antigen receptor T cell |
| SCID | Severe combined immunodeficiency |
| GVHD | Graft-versus-host disease |
| HSC | Hematopoietic stem cells |
| PBLs | Peripheral blood leukocytes |
| PBMCs | Peripheral blood mononuclear cells |
| ADCC | Antibody-dependent cellular cytotoxicity |
| ZFNs | Zinc finger nucleases |
| TALENs | Transcription activator-like effector nucleases |
| CRISPR-Cas9 | Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 |
| NK cell | Natural killer cell |
| HAND | HIV associated neurocognitive disorders |
| SIV | Simian immunodeficiency virus |
| SHIV | Simian human immunodeficiency virus |
| AAV | Adeno-associated virus |
| LTR | Long terminal repeat |